FDA’s Technology Modernization Action Plan
The plan describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data, and analytics—to advance FDA’s public health mission.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Food & Beverages
Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP, 150mg and 300mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL, Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity
American Health Packaging Issues Voluntary Nationwide Recall of Ranitidine Syrup (Ranitidine Oral Solution USP) 150 mg/10 mL Liquid Unit Dose Cups Due to the Detection of N-nitrosodimethylamine (NDMA) Impurity
Patient Perspective Is Vital to FDA's Work
FDA considers patients the real experts when it comes to their health conditions, as illustrated in the recent rare disease disorder summit.
To Help Reduce Drug Shortages, We Need Manufacturers to Sell Quality
Drug manufacturers with very high reliability usually have a mature quality management system — purchasers should have the ability to readily identify them.
Expanding Criminal Enforcement Operations Globally to Protect Public Health
FDA’s inspections, investigations, and law enforcement operations are led by FDA's Office of Regulatory Affairs.